We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Aarti Pharmalabs Limited | 4319.02 | 479.56 | 4322.73 | 5.29 | 7,469 | 28.0 |
| Marksans Pharma Limited | 7745.71 | 1136.9 | 7544.27 | 2.5 | 7449 | 21.3 |
| FDC Limited | 4855.06 | 283.03 | 4647.08 | 1.74 | 7394 | 27.5 |
Aarti Pharmalabs Limited, with Security Code 543748, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 373.0 | 414.8 | 393.5 | 377.3 | 470.9 | 529.6 | 375.3 | 417.3 |
| Expenses | 284.8 | 307.5 | 309.8 | 292.5 | 356.0 | 386.5 | 280.2 | 343.3 |
| Operating Profit | 88.3 | 107.3 | 83.7 | 84.8 | 115.0 | 143.1 | 95.1 | 74.0 |
| OPM % | 23.66% | 25.88% | 21.26% | 22.47% | 24.42% | 27.03% | 25.35% | 17.73% |
| Other Income | 0.2 | 5.7 | 2.1 | 2.9 | 11.9 | -2.5 | 1.6 | 3.1 |
| Interest | 4.1 | 4.4 | 4.2 | 5.4 | 9.7 | 6.3 | 6.8 | 10.7 |
| Depreciation | 16.9 | 17.3 | 18.3 | 18.9 | 21.0 | 20.8 | 22.8 | 24.8 |
| Profit before tax | 67.4 | 91.3 | 63.2 | 63.4 | 96.2 | 113.5 | 67.2 | 41.7 |
| Tax % | -28.5% | -31% | -25.4% | 24.6% | -23.6% | -21.7% | 23.7% | 25.8% |
| Net Profit | 48.2 | 63.0 | 47.1 | 47.8 | 73.5 | 88.8 | 51.2 | 30.9 |
| EPS in Rs | 5.32 | 6.95 | 5.2 | 5.27 | 8.11 | 0 | 5.65 | 3.41 |
| Metrics | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Dec 2025 | Dec 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 458.0 | 537.8 | 563.8 | 418.3 | 432.3 | 432.3 | 432.3 | 432.3 |
| Expenses | 364.4 | 409.2 | 418.1 | 344.3 | 330.0 | 330.0 | 330.0 | 330.0 |
| Operating Profit | 93.7 | 128.6 | 145.7 | 74.1 | 102.3 | 102.3 | 102.3 | 102.3 |
| OPM % | 20.45% | 23.92% | 25.84% | 17.71% | 23.67% | 23.67% | 23.67% | 23.67% |
| Other Income | 4.5 | 5.0 | -1.6 | 0.1 | -3.2 | -3.2 | -3.2 | -3.2 |
| Interest | 5.5 | 10.0 | 6.6 | 10.7 | 12.6 | 12.6 | 12.6 | 12.6 |
| Depreciation | 20.9 | 23.0 | 22.8 | 24.8 | 28.6 | 28.6 | 28.6 | 28.6 |
| Profit before tax | 71.8 | 100.6 | 114.7 | 38.7 | 60.7 | 60.7 | 60.7 | 60.7 |
| Tax % | -23.9% | 26.5% | -22.9% | -27.4% | 25.7% | 25.7% | 25.7% | 25.7% |
| Net Profit | 54.6 | 74.0 | 88.3 | 27.9 | 48.0 | 48.0 | 48.0 | 48.0 |
| EPS in Rs | 6.02 | 8.16 | 0 | 0 | 5.29 | 5.29 | 5.29 | 5.29 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 23% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 564% |
| 3 Years: | 34% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 44% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 21% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 31% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 44% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|